EMESAFENE

This brand name is authorized in Netherlands.

Active ingredients

The drug EMESAFENE contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Meclozine UNII `3L5TQ84570` - MECLIZINE
	Meclizine is a first generation antihistamine that is used largely to treat vertigo and motion sickness.
	Read more about Meclozine
`2`	Pyridoxine UNII `KV2JZ1BI6Z` - PYRIDOXINE
	Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition.
	Read more about Pyridoxine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AE55	Meclozine, combinations	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE55

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NL	Z-Index G-Standaard, PRK	14990, 3131

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.